Back to search
TGCT
Clinical trial pipeline · Data from ClinicalTrials.gov
See which TGCT trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which TGCT trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary purpose of this study is to assess the tolerability, pharmacokinetics, and efficacy of pimicotinib in Japanese participants with TGCT
Background: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a d…
The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participan…
The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose…
This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
Testicular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suf…
Background: People with a family history of testicular cancer may be at increased risk for the disease. Genetic and clinical studies of patients with testicul…
This is a multicenter, Phase 3, randomised, double-blind, placebo-controlled study, which aims to evaluate the efficacy and safety of the investigational drug e…